openPR Logo
Press release

Label-Free Detection Systems Market - Key Growth Factors and Industry Analysis 2020

Label-Free Detection Systems Market - Key Growth Factors

Drug discovery market is growing at a significant rate due to high investments from pharmaceutical companies and academic institutes in R&D of innovative products. Drug delivery processes involve target identification and screening of drugs. Label-free detection systems refer to the integrated systems that investigate about the biomolecular interactions without quenching of labels or auto-fluorescent effects. These systems provide rapid and real time approach for new drug discovery.

Label-free detection systems may be used to detect both biochemical and cell-based assays. High acceptance rate for the use of this technology in pharmaceutical and biotechnology sector due to various advantages involved with the process are driving the global label-free detection systems market. On the basis of applications, label-free detection systems market may be segmented into binding thermodynamics, hit confirmation, binding kinetics, lead generation, endogenous receptor detection and others. Out which binding kinetics segment has the largest market.

Request for Report TOC @ https://www.persistencemarketresearch.com/toc/3085

On the basis of technology used, surface plasmon resonance technology segment has the largest share in the global label-free detection systems market. However, bio-layer interferometry segment is expected to grow at the fastest rate. This is due to less fluctuation in the refractive index of the samples being tested and microfluidic-free nature of bio-layer interferometry label-free detection systems. North America dominates the global label-free detection systems market due to technological advancement and high government funding in the region. Europe followed by Asia is expected to experience high growth rate in the next few years in global label-free detection systems market. Some of the key driving forces for label-free detection systems market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.

Increased R&D investments in drug discovery from various pharmaceutical and biotechnology companies, rising government funding and growing number drug discovery programs by various academic institutions is driving the global label-free detection systems market. However, high cost involved and increasing consolidation of pharmaceutical and biotechnology companies are restraining the growth of global label-free detection systems market.

Request for Report Sample @ https://www.persistencemarketresearch.com/samples/3085

Increasing adoption rate for label-free technology in various industries is expected to offer good opportunity for growth of label-free detection systems market. In addition, advancement in the features offered in label-free detection systems, such as lower analysis time and higher sensitivity is expected to drive the label-free detection systems market. Some of the key trends that have been observed in label-free detection systems market are major companies dealing in label-free detection market involved in expanding their geographical presence and new product launches with innovative technologies. Some of the major companies dealing in label-free detection systems market are Bio-Rad Laboratories, Inc., General Electric Corporation, Corning, Inc., PerkinElmer Inc., SRU Biosystems, Inc. and X-BODY Biosciences, Inc. Other market players with significant presence are CSEM (Centre Suisse d'Electronique et Microtechnique SA), BiOptix, AMETEK, Inc, Attana AB, Danaher Corporation, Pall Corporation and F. Hoffmann-La Roche Ltd.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Label-Free Detection Systems Market - Key Growth Factors and Industry Analysis 2020 here

News-ID: 754055 • Views:

More Releases from Persistence Market Research

Mauritia Flexuosa Fruit Oil Market Set for Steady Growth at 8.5% CAGR Through 2032
Mauritia Flexuosa Fruit Oil Market Set for Steady Growth at 8.5% CAGR Through 20 …
The global Mauritia flexuosa fruit oil market is witnessing steady expansion as demand for plant-based, nutrient-rich oils rises across cosmetics, nutraceuticals, and functional food industries. The market is likely to be valued at US$240.4 million in 2025 and is projected to reach US$425.5 million by 2032, registering a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032. This growth reflects increasing consumer awareness of natural ingredients and the
Hepatocellular Carcinoma (HCC) Treatment Market Size to Grow at 8.8% CAGR Through 2033 - Persistence Market Resaerch
Hepatocellular Carcinoma (HCC) Treatment Market Size to Grow at 8.8% CAGR Throug …
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, primarily stemming from underlying liver diseases such as chronic viral hepatitis (HBV and HCV), alcohol-related liver damage, and metabolic disorders. Over the years, the HCC treatment market has experienced significant growth, driven by advancements in therapeutic strategies, early diagnosis, and improved healthcare access. In this article, we will explore the current trends, growth drivers, challenges, opportunities, and key players
Inhalation CDMO Market to Reach US$14.3 Bn by 2033 at 6.0% CAGR - Persistence Market Resaerch
Inhalation CDMO Market to Reach US$14.3 Bn by 2033 at 6.0% CAGR - Persistence Ma …
The Inhalation Contract Development and Manufacturing Organization (CDMO) market is witnessing substantial growth, driven by the increasing prevalence of respiratory diseases and the rising demand for complex inhalation drug-device combination products. This market, valued at $9.5 billion in 2026, is projected to grow to $14.3 billion by 2033, with a CAGR of 6.0%. The emergence of new technologies, rising outsourcing trends, and growing regulatory expertise have all played pivotal roles
Septoplasty Market to Reach US$5.4Bn by 2033 at 7.3% CAGR - Persistence Market Resaerch
Septoplasty Market to Reach US$5.4Bn by 2033 at 7.3% CAGR - Persistence Market R …
The global septoplasty market is on a significant upward trajectory, driven by a combination of demographic shifts, increasing healthcare awareness, and rapid technological advancements. In 2026, the market is projected to be valued at approximately US$ 3.3 billion and is expected to reach US$ 5.4 billion by 2033, growing at a robust compound annual growth rate (CAGR) of 7.3% during the forecast period from 2026 to 2033. Septoplasty, a surgical

All 5 Releases


More Releases for R&D

Sales Acceleration Technology Market 2023: Sales and Industry Revenue Forecasts- …
The Sales Acceleration Technology market has witnessed growth from USD XX million to USD XX million from 2017 to 2023. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Sales Acceleration Technology market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain. Technological
R&D Incentive Services Market is Booming Worldwide | KPMG, R&D Incentives, Deloi …
The latest report released on Global R&D Incentive Services Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the R&D Incentive Services Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend, growth factors and estimates for Global R&D Incentive Services Market forecasted till 2028. Some of the key players profiled are KPMG
Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University